跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLATECT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GLATECT
Authorized
STANDARD
GLATECT
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
53bb3573127d8988
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
53bb3573127d8988
Drug Approval Canada Name
GLATECT
Product Name
GLATECT
Status
Marketed
Status Date
2017-08-21
Original Market Date
2017-08-21
Din
02460661
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
92:20.00
Atc Original
L03AX13 GLATIRAMER ACETATE
Atc Name
l 03 ax 13
Aig Number
0132525001
Company Name
Pharmascience Inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Active Ingredients
GLATIRAMER ACETATE
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
53bb3573127d8988
Type
Standard
Back to Health Canada Approvals